Trademark: 90257113
Word
RECURSION IS INDUSTRIALIZING DRUG DISCOVERY
Status Date
Monday, January 29, 2024
Filing Date
Thursday, October 15, 2020
Published for Opposition
Tuesday, May 4, 2021
Abandoned Date
Monday, January 29, 2024
9 Downloadable computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Recorded computer software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds
42 Pharmaceutical research and development services; scientific research and development of pharmaceutical preparations; pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; contract research services in support of scientific research and development of pharmaceutical preparations; technical consultancy and services in relation to technical research in the field of pharmaceuticals; consultancy in relation to scientific research in the field of pharmaceuticals; providing medical research and scientific research information in the field of medicine and pharmaceuticals; drug discovery services; drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds
Jan 29, 2024
Abandonment Notice E-Mailed - No Use Statement Filed
Jan 29, 2024
Abandonment - No Use Statement Filed
Jul 1, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2023
Sou Extension 4 Granted
Jun 29, 2023
Sou Extension 4 Filed
Jun 29, 2023
Sou Teas Extension Received
Dec 31, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 29, 2022
Sou Extension 3 Granted
Dec 29, 2022
Sou Extension 3 Filed
Dec 29, 2022
Sou Teas Extension Received
Jul 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 29, 2022
Sou Extension 2 Granted
Jun 29, 2022
Sou Extension 2 Filed
Jun 29, 2022
Sou Teas Extension Received
Dec 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 15, 2021
Sou Extension 1 Granted
Dec 15, 2021
Sou Extension 1 Filed
Dec 15, 2021
Sou Teas Extension Received
Jun 29, 2021
Noa E-Mailed - Sou Required From Applicant
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 4, 2021
Published For Opposition
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Apr 1, 2021
Approved For Pub - Principal Register
Mar 23, 2021
Examiner's Amendment Entered
Mar 23, 2021
Notification Of Examiners Amendment E-Mailed
Mar 23, 2021
Examiners Amendment E-Mailed
Mar 23, 2021
Examiners Amendment -Written
Mar 16, 2021
Assigned To Examiner
Dec 3, 2020
New Application Office Supplied Data Entered
Oct 29, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 29, 2020
Teas Change Of Correspondence Received
Oct 29, 2020
Teas Change Of Owner Address Received
Oct 19, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
